Covered recipient · General Payments record
SUNITHA POLEPALLE
General Payments · PY2018–2024
$3,794.44
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $782.42 | 9 |
| Travel and Lodging | $595.88 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Curonix LLC | $687.76 | 7 |
| Acerta Pharma LLC | $240.00 | 2 |
| Teva Pharmaceuticals USA, Inc. | $125.00 | 1 |
| Abbott Laboratories | $123.51 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $123.44 | 1 |
| SPR Therapeutics, Inc | $78.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $123.51 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125374685 | CMS |
| AstraZeneca Pharmaceuticals LP | $115.00 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110553066 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110540327 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $123.44 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117862468 | CMS |
| Curonix LLC | $265.32 | 01/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132911703 | CMS |
| Curonix LLC | $4.51 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132911705 | CMS |
| Curonix LLC | $74.24 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132911707 | CMS |
| Curonix LLC | $58.48 | 01/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132911709 | CMS |
| Curonix LLC | $222.08 | 01/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132911711 | CMS |
| Curonix LLC | $13.13 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132911713 | CMS |
| Curonix LLC | $50.00 | 01/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132911715 | CMS |
| SPR Therapeutics, Inc | $78.59 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104955647 | CMS |
| Teva Pharmaceuticals USA, Inc. | $125.00 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151586394 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.